A Closer Look at Johnson & Johnson's Options Market Dynamics - Johnson & Johnson (NYSE:JNJ)

Core Viewpoint - Investors are showing a bullish sentiment towards Johnson & Johnson (NYSE: JNJ), indicated by significant options trading activity, suggesting that large investors may anticipate upcoming developments [1][2]. Options Trading Activity - A total of 38 uncommon options trades for Johnson & Johnson were identified, with 26 calls amounting to $2,847,461 and 12 puts totaling $701,701, reflecting a mixed sentiment among traders [2][3]. - The overall sentiment from big-money traders is approximately 50% bullish and 36% bearish, indicating a notable interest in the stock [3]. Price Targets - The targeted price range for Johnson & Johnson's stock over the last three months has been identified between $145.0 and $255.0, based on the volume and open interest of options contracts [4]. Volume and Open Interest - The analysis of volume and open interest provides insights into the liquidity and investor interest in Johnson & Johnson's options, particularly within the strike price range of $145.0 to $255.0 over the past 30 days [5]. Current Market Status - Johnson & Johnson is recognized as the world's largest and most diverse healthcare firm, focusing on innovative medicine and medtech after divesting its consumer business, Kenvue, in 2023 [10]. - The company’s drug division is concentrating on three main therapeutic areas: immunology, oncology, and neurology, with over half of its total revenue generated in the United States [10]. Analyst Ratings - Recent professional analyst ratings indicate an average price target of $190.0 for Johnson & Johnson, with one analyst revising their rating downward to Hold [11][12]. Trading Metrics - The current trading volume for Johnson & Johnson stands at 7,976,739, with the stock price at $202.11, reflecting a 1.06% increase [14].